You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team
Regimen
Published Date: 09 Oct 2025
Cancer Type:
Gastrointestinal, 
Rectal
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant
Oct 2025
Regimen
Published Date: 09 Oct 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Oct 2025
Drug

Published Date: 06 Oct 2025

Revision Summary:
Drug Monograph: Updated antidote information
Oct 2025
Drug

Published Date: 29 Sep 2025

Revision Summary:
Drug Monograph: New drug monograph
Patient Info Sheet EN: New patient information sheet
Sep 2025
Regimen
Published Date: 29 Sep 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Expanded to full regimen monograph

Sep 2025
Drug

Published Date: 26 Sep 2025

Revision Summary:
Patient Info Sheet EN: Updated/Revised information sheet
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Sep 2025
Drug

Published Date: 26 Sep 2025

Revision Summary:
Patient Info Sheet EN: Updated/Revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Sep 2025
Drug

Published Date: 26 Sep 2025

Revision Summary:
Patient Info Sheet EN: Updated/Revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Sep 2025
Regimen
Published Date: 26 Sep 2025
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, Drug Administration and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline.

Sep 2025
Regimen
Published Date: 26 Sep 2025
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, Drug Administration and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline.

Sep 2025
Drug

Published Date: 26 Sep 2025

Revision Summary:
Patient Info Sheet EN: Updated/Revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Sep 2025
Drug

Published Date: 26 Sep 2025

Revision Summary:
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Sep 2025

Pages